Pliant Therapeutics Inc - ESG Rating & Company Profile powered by AI
The Disclosure score includes seventeen UN SDGs including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. Detailed ESG analysis of Pliant Therapeutics Inc can be accessed by registering for free. If you are employed by Pliant Therapeutics Inc and you would like to licence your Sustainability rating, please get in touch.
Pliant Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.8; made up of an environmental score of 8.0, social score of 4.8 and governance score of 1.6.
4.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 764 | Zoetis Inc | 4.9 | High |
| 764 | iCo Therapeutics Inc | 4.9 | High |
| 816 | Pliant Therapeutics Inc | 4.8 | High |
| 816 | Chemomab Therapeutics Ltd | 4.8 | High |
| 816 | Althea Group Holdings Ltd | 4.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Pliant Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Pliant Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Pliant Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Pliant Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Pliant Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pliant Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pliant Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Pliant Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Pliant Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Pliant Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pliant Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pliant Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pliant Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pliant Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Pliant Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Pliant Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pliant Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pliant Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in Phase II single ascending dose/multiple ascending dose trails and completed Phase Ib proof-of-mechanism trials for the treatment of idiopathic pulmonary fibrosis and primary sclerosing cholangitis. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was founded in 2015 and is based in South San Francisco, California.